Alcohol increases rectal cancer risk, but risk is smaller among regular wine drinkersMay 09, 2003Regular drinkers significantly increase their risk of rectal cancer, but that risk is reduced if wine makes up a third or more of weekly consumption, suggests research in Gut. The findings are based on a population study of over 29,000 Danish men and women aged between 23 and 95. Their weekly intake of beer, wine, and spirits was assessed, as were other factors likely to influence bowel cancer risk, such as how much they smoked, weighed, and took regular exercise. Men were more likely than women to be heavy drinkers, and heavy drinkers were more likely to be smokers and to weigh more than light drinkers. During a monitoring period of almost 15 years, 411 cases of colon cancer and 202 cases of rectal cancer were reported among those studied. Alcohol seemed to have little influence over the risk of colon cancer, but there was a clear association between rectal cancer risk and the amount of alcohol consumed. Those drinking more than 41 units of alcohol a week had twice the risk of developing the disease as non-drinkers. But the type of alcohol consumed had a significant bearing on rectal cancer risk. Those who drank 14 or more units of beer or spirits a week were over 3.5 times as likely to develop rectal cancer as non-drinkers. Yet those who drank the same total amount of alcohol, but who included around a third or more of wine in their intake were less than twice as likely to develop the disease. The authors point out that wine drinkers tended to be better educated and to take more exercise than beer or spirit drinkers, so there may be other healthier lifestyle factors at play. There are no obvious reasons why alcohol should apparently be more damaging to the rectum than the colon, say the authors, but the reasons why wine seems to exert its protective effect most likely lie in resveratrol, which is found in both grapes and wine. Previous research indicates that this chemical damps down the cellular processes involved in the promotion and growth of cancerous cells. | |||||||||||||||||||||
|
Related Colon Cancer News Articles 'Smothered' genes combine with mutations to yield poor outcome in cancer patients Johns Hopkins Kimmel Cancer Center researchers have identified a set of genes in breast and colon cancers with a deadly combination of traditional mutations and "smothered" gene activity that may result in poor outcomes for patients. Study finds that significant proportion of men told wife's cancer was incurable late or not at all A study conducted in Sweden found that more than 40 percent of widowers in that country whose wives died from cancer four or five years earlier reported they were either never told that their spouse's cancer was incurable, or they heard this information during the last week of her life. Different type of colon cancer vaccine reduces disease spread, Jefferson scientists show Taking advantage of the fact that the intestines have a separate immune system from the rest of the body, scientists at the Kimmel Cancer Center at Jefferson in Philadelphia have found a way to immunize mice against the development of metastatic disease. Weight-loss surgery can cut cancer risk Successful bariatric surgery allows morbidly obese patients to lose up to 70 percent of their excess weight and to maintain weight loss. Obese women in Canada are less likely to be screened for cervical cancer Research in the United States has shown that obese people are less likely than their normal-weight peers to undergo screening for breast, colon and cervical cancer. Raj Padwal, Rebecca Mitchell and Scott Klarenbach, from the University of Alberta's Faculty of Medicine & Dentistry, have undertaken a study to see if this trend is also true in Canada. Prevalence of pre-cancerous masses in the colon same in patients in their 40s and 50s The prevalence of pre-cancerous masses in the colon is the same for average-risk patients who are 40 to 49 years of age and those who are 50 to 59 years of age. Prevalence of pre-cancerous masses in the colon same in patients in their 40s and 50s The prevalence of pre-cancerous masses in the colon is the same for average-risk patients who are 40 to 49 years of age and those who are 50 to 59 years of age, reports a new study in Gastroenterology, the official journal of the American Gastroenterological Association (AGA) Institute. Smokers with advanced colon cancer may face higher odds of disease recurrence People with advanced colon cancer who have smoked cigarettes or used other tobacco products for many years may have an increased risk that their colon cancer will return, according to research by Dana-Farber Cancer Institute scientists to be presented at the annual meeting of the American Society of Clinical Oncology (ASCO), May 30-June 3, in Chicago. New method proposed for determining which patients should get treatment for colorectal cancer A new study being presented at the American Society of Clinical Oncology meeting in Chicago (Abstract #4020), may change treatment practice in about 25 percent of patients with colon cancer and is the basis for proposed changes to the way colorectal cancers will be staged. CAPHOSOL relieves oral mucositis and improves quality-of-life in cancer patients New data show that CAPHOSOL® (www.caphosol.com), an advanced electrolyte solution, relieves painful oral mucositis (OM) and improves quality of life for cancer patients undergoing chemotherapy and radiation therapy. More Colon Cancer News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||